Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
First Tracks Biotherapeutics, Inc. (TRAX) had Free Cash Flow per Share of $-1.84 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-33.37M |
|
-- |
|
-- |
|
$34.94M |
|
$-34.94M |
|
$1.56M |
|
$-33.37M |
|
$-33.37M |
|
$-33.37M |
|
$-33.37M |
|
$-33.37M |
|
$-33.37M |
|
$-34.94M |
|
$-34.58M |
|
35.00M |
|
35.00M |
|
$-0.95 |
|
$-0.95 |
|
| Balance Sheet Financials | |
$177.75M |
|
$1.07M |
|
$5.39M |
|
$183.14M |
|
$12.45M |
|
-- |
|
$1.90M |
|
$14.34M |
|
$168.80M |
|
$168.80M |
|
$168.80M |
|
35.39M |
|
| Cash Flow Statement Financials | |
$-64.48M |
|
$34.96M |
|
$-40.66M |
|
$238.20M |
|
$168.02M |
|
$-70.18M |
|
$19.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-64.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.77% |
|
-19.77% |
|
-18.22% |
|
-19.77% |
|
$4.77 |
|
|
Free Cash Flow per Share |
$-1.84 |
$-1.84 |
|